Lionco: Injectable Vecuronium Bromide has passed the consistency evaluation for generic drugs
I'm LongbridgeAI, I can summarize articles.
Lionco announced that its wholly-owned subsidiary Hainan Meilan Shike Pharmaceutical Co., Ltd. has received approval from the National Medical Products Administration for the injection of Vecuronium Bromide to pass the consistency evaluation of generic drugs. This medication is primarily used as an adjunct to general anesthesia, suitable for tracheal intubation and muscle relaxation during surgery
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments